Vetigenics Founder Nicola Mason Featured on CBS 60 Minutes for Canine Cancer Research
Nicola Mason, BVetMed, PhD, of Penn Vet was featured on CBS' 60 Minutes, where she spoke about her research on immunotherapy treatment for cancer in dogs.
Avisi Technologies Closes $4 Million Seed Round to Further Develop Glaucoma Treatment Device
Penn spinout Avisi Technologies raised $4.06 million in a seed round led by Accanto Partners.
Penn Today Interviews John Swartley About PCI’s Impact
In the article, Swartley discusses some key highlights from FY22, including the major impact Penn technologies have made on patients.
Pennovation Works Welcomes New Director Denita Henderson
Henderson, Penn alumna and Philly native, will spearhead the implementation of Pennovation’s long-range strategic plan, including development of the site, marketing, communications and leasing.
Penn Dental Medicine Study Finds That Cavity-causing Microbes Have the Ability to Form Superorgranisms that Can Crawl on Teeth
A Penn Dental Medicine study found that cavity-causing microbes have the ability to form superorgranisms that can sprout “limbs” that propel them to“leap” to quickly spread on the tooth surfaces.
Neuralert Technologies included in TIME’s List of the Best Inventions
The lightweight, non-invasive wristband device can detect the stroke symptoms in as little as 15 minutes.
Emily Whitehead’s CAR-T Cell Therapy Journey Featured on CBS
CBS This Morning recently featured a story about Emily Whitehead, the first pediatric patient to receive Penn-invented CAR T cell therapy to fight cancer.
PCI Ventures Presents at Pennovation Works Showcase
The PCI Ventures at Pennovation Works Showcase took place in October 2022, in celebration of Pennovation Works' 6th Anniversary and PCI Ventures' 12 years of service to the Penn community.
PCI Ventures @ Pennovation Works Showcase Shines Spotlight on Penn-Affiliated Startups Making a Difference
PCI Ventures, a division of PCI specifically focused on creating early-stage businesses founded on Penn technology, recently held a showcase at Pennovation Works.
Drew Weismann Speaks on the Future of mRNA Technology in Bloomberg’s “The Big Take” Podcast
Weissman talks about his discovery and the impact of mRNA technology on the development of therapies for flu, cancer and rare genetic diseases.